Lifeline Biotechnologies, Inc. (LLBO) is a publicly traded company in the Healthcare sector, operating within the Medical - Devices industry. The company is headquartered in Reno, NV, United States. The current CEO is James D. Holmes.
LLBO has IPO date of 1995-02-02, listed on the Other OTC, a market capitalization of $2.61M.
Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis, and quick recovery of various diseases. The company offers First Warning System, a non-invasive, non-compressive, and non-radiogenic device used in assisting the early discovery of breast tissue abnormalities in women. It also provides Mastascope, a hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast; and OVASCOPE, an ultra slim endoscope to directly visualize the ovarian surface in the search for cancer. The company also has operations in Europe. Lifeline Biotechnologies, Inc. is headquartered in Reno, Nevada.
